FI973040A0 - Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessa - Google Patents

Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessa

Info

Publication number
FI973040A0
FI973040A0 FI973040A FI973040A FI973040A0 FI 973040 A0 FI973040 A0 FI 973040A0 FI 973040 A FI973040 A FI 973040A FI 973040 A FI973040 A FI 973040A FI 973040 A0 FI973040 A0 FI 973040A0
Authority
FI
Finland
Prior art keywords
levobupivacaine
aesthetics
preparation
carboxanilide
compound
Prior art date
Application number
FI973040A
Other languages
English (en)
Swedish (sv)
Other versions
FI117437B (fi
FI973040A (fi
Inventor
Ulrich Conrad Dyer
Marianne Langston
Martin Woods
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of FI973040A0 publication Critical patent/FI973040A0/fi
Publication of FI973040A publication Critical patent/FI973040A/fi
Application granted granted Critical
Publication of FI117437B publication Critical patent/FI117437B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Rolling Contact Bearings (AREA)
  • Optical Head (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI973040A 1995-01-18 1997-07-17 Menetelmä optisesti rikastetun levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidiyhdisteiden rasemisoimiseksi FI117437B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9501071 1995-01-18
GBGB9501071.6A GB9501071D0 (en) 1995-01-18 1995-01-18 Racemisation
GB9600067 1996-01-12
PCT/GB1996/000067 WO1996022281A1 (en) 1995-01-18 1996-01-12 Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents

Publications (3)

Publication Number Publication Date
FI973040A0 true FI973040A0 (fi) 1997-07-17
FI973040A FI973040A (fi) 1997-07-17
FI117437B FI117437B (fi) 2006-10-13

Family

ID=10768271

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973040A FI117437B (fi) 1995-01-18 1997-07-17 Menetelmä optisesti rikastetun levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidiyhdisteiden rasemisoimiseksi

Country Status (20)

Country Link
EP (1) EP0804417B1 (fi)
JP (1) JP4015696B2 (fi)
KR (1) KR100404390B1 (fi)
CN (1) CN1172912C (fi)
AT (1) ATE242214T1 (fi)
AU (1) AU701221B2 (fi)
BR (1) BR9606821A (fi)
CA (1) CA2208522C (fi)
DE (1) DE69628540T2 (fi)
DK (1) DK0804417T3 (fi)
ES (1) ES2201166T3 (fi)
FI (1) FI117437B (fi)
GB (1) GB9501071D0 (fi)
HU (1) HU227426B1 (fi)
MX (1) MX9705428A (fi)
NO (1) NO308843B1 (fi)
PL (1) PL184091B1 (fi)
PT (1) PT804417E (fi)
WO (1) WO1996022281A1 (fi)
ZA (1) ZA96403B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
LT2767292T (lt) 2004-09-17 2016-12-12 Durect Corporation Palaikomosios vietinės anestezijos mišinys su saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
WO2023158722A2 (en) * 2022-02-16 2023-08-24 Teva Pharmaceuticals International Gmbh Processes for preparation of avacopan and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301498A1 (fr) * 1975-02-20 1976-09-17 Maggioni & C Spa Methode pour la racemisation d'une lysine optiquement active

Also Published As

Publication number Publication date
DE69628540D1 (de) 2003-07-10
JPH11501905A (ja) 1999-02-16
NO973312D0 (no) 1997-07-17
MX9705428A (es) 1997-11-29
ATE242214T1 (de) 2003-06-15
KR100404390B1 (ko) 2004-01-31
NO973312L (no) 1997-07-17
HUP9901418A3 (en) 2001-01-29
AU4394896A (en) 1996-08-07
KR19980701432A (ko) 1998-05-15
NO308843B1 (no) 2000-11-06
CN1168134A (zh) 1997-12-17
PT804417E (pt) 2003-09-30
BR9606821A (pt) 1997-12-23
HUP9901418A2 (hu) 1999-08-30
EP0804417A1 (en) 1997-11-05
GB9501071D0 (en) 1995-03-08
DE69628540T2 (de) 2004-01-08
EP0804417B1 (en) 2003-06-04
CN1172912C (zh) 2004-10-27
DK0804417T3 (da) 2003-10-06
CA2208522A1 (en) 1996-07-25
PL321378A1 (en) 1997-12-08
FI117437B (fi) 2006-10-13
HU227426B1 (en) 2011-05-30
WO1996022281A1 (en) 1996-07-25
ZA96403B (en) 1997-01-20
AU701221B2 (en) 1999-01-21
FI973040A (fi) 1997-07-17
CA2208522C (en) 2007-03-13
PL184091B1 (pl) 2002-08-30
JP4015696B2 (ja) 2007-11-28
ES2201166T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
FI973040A (fi) Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessa
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
AU3738597A (en) Molecular model for vla-4 inhibitors
DE69606210D1 (de) Doppelkammerbehälter und Verfahren zu seiner Herstellung
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
DK0859766T3 (da) Chirale methylphenyloxazolidinoner
ATE217633T1 (de) Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
DE69624825D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
TR199800608A3 (tr) Propanolamin türevleri, bunlarin üretim usulü.
NO961000D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
DE59604829D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
NO304828B1 (no) Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
DE69610837D1 (de) Verfahren zur herstellung von laubholzelementen
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
ATE237621T1 (de) Herstellung von einem kristallinen amoxicillinsalz
ATE241356T1 (de) Verlängerung der expression von transgenen proteinen durch immunmodulierende behandlung mit 15-deoxyspergualin
ATE212969T1 (de) Verfahren zur herstellung von 2-halogenindan-1- onen
DE69802171D1 (de) Verfahren zur herstellung von 10,11-dihydro-5h-dibenzo(a,d)cyclohept-5-enen und ihren derivaten
ATE236192T1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
NO20023386D0 (no) Pseudopolymorf av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on
DE59808476D1 (de) VERFAHREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ENTHALTEND HMG-CoA- REDUKTASEINHIBITOREN

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117437

Country of ref document: FI

MA Patent expired